Biotechnology Brexit Impact On Drugs – Rising Shortages in UK Highlight Brexit Challenges – AstraZeneca (NASDAQ:AZN), Johnson & Johnson (NYSE:JNJ), GSK (NYSE:GSK) Read more
Biotechnology Once Valued At Billions, 23andMe’s CEO Considers Privatization To Secure Company’s Future – 23andMe Holding (NASDAQ:ME) Read more
Biotechnology GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years – GSK (NYSE:GSK) Read more
Biotechnology CureVac, GSK Partner Release Data On Influenza Vaccine Study – CureVac (NASDAQ:CVAC), GSK (NYSE:GSK) Read more
Biotechnology GSK Reveals New Phase 3 Data For Jemperli Combo Therapy To Support Expanded Use Approval For Wider Endometrial Cancer – GSK (NYSE:GSK) Read more
Biotechnology Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt ‘Barbell Approach’ – AstraZeneca (NASDAQ:AZN), ASML Holding (NASDAQ:ASML) Read more
Biotechnology GSK's Withdrawn Multiple Myeloma Drug Shows Encouraging Combination Therapy Data In Second Late-Stage Study Read more
Biotechnology Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows – GSK (NYSE:GSK), Pfizer (NYSE:PFE) Read more
Biotechnology Pfizer/GSK-Backed ViiV Healthcare’s HIV Drug Associated With Increased Resistance, WHO Report Says – GSK (NYSE:GSK), Pfizer (NYSE:PFE) Read more
Biotechnology Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges – Gilead Sciences (NASDAQ:GILD), GSK (NYSE:GSK) Read more
